![Joseph Miller](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Joseph Miller
Keine laufenden Positionen mehr
Vermögen: 9 Mio $ am 31.05.2026
Profil
Joseph M.
Miller worked as Chief Financial Officer & Vice President-Finance at Eppendorf, Inc. and Eppendorf-5 Prime, Inc. from 2002 to 2006.
From 2006 to 2015, Mr. Miller was Senior Director-Accounting at Qiagen Genomics, Inc. and QIAGEN NV.
Between 2015 and 2018, Mr. Miller served as Vice President-Finance at Sucampo Pharmaceuticals LLC.
From 2020 to 2022, Mr. Miller was Director at Avalo Therapeutics, Inc. Mr. Miller's education includes an undergraduate degree from Villanova University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 02.03.2026 | 576.421 ( 0,45 % ) | 9 Mio $ | 31.05.2026 |
Ehemalige bekannte Positionen von Joseph Miller
| Unternehmen | Position | Ende |
|---|---|---|
| AURINIA PHARMACEUTICALS INC. | Finanzdirektor/CFO | 20.03.2026 |
| AVALO THERAPEUTICS, INC. | Finanzdirektor/CFO | 24.04.2020 |
| SUCAMPO PHARMACEUTICALS, INC. | Finanzdirektor/CFO | 01.04.2018 |
Qiagen Genomics, Inc.
 Qiagen Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and technology in the bioscience area | Comptroller/Controller/Auditor | 01.01.2015 |
| QIAGEN N.V. | Comptroller/Controller/Auditor | 01.01.2015 |
Ausbildung von Joseph Miller
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
53
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
QIAGEN NV
 QIAGEN NV Medical SpecialtiesHealth Technology Manufactures and distributes sample and assay technology products for pre-analytical sample preparations | Health Technology |
Eppendorf, Inc.
 Eppendorf, Inc. BiotechnologyHealth Technology Manufactures bio-tech products | Health Technology |
Qiagen Genomics, Inc.
Qiagen Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and technology in the bioscience area | Commercial Services |
Villanova University
 Villanova University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sucampo Pharmaceuticals LLC
 Sucampo Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures prostone based pharmaceuticals products | Health Technology |
Eppendorf-5 Prime, Inc. | |
Avalo Therapeutics, Inc.
 Avalo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for patients with unmet clinical need in immunology and rare genetic diseases | Health Technology |
Aurinia Pharmaceuticals, Inc.
 Aurinia Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics | Health Technology |
Wählen Sie MarketScreener 
